
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $834M | $1.2B | $1.4B | $1.5B | $1.5B | |
Revenue Growth (YoY) | -- | 44.38% | 19.36% | 4.39% | 2.49% | |
Cost of Revenues | $353.5M | $474.5M | $599.9M | $619.7M | $669.7M | |
Gross Profit | $480.6M | $729.7M | $837.3M | $880.6M | $867.9M | |
Gross Profit Margin | 57.62% | 60.6% | 58.26% | 58.7% | 56.44% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $394.8M | $470.2M | $575.3M | $677.6M | $668.2M | |
Other Inc / (Exp) | -$48K | -$51M | -$17.2M | $4.8M | -$7.3M | |
Operating Expenses | $473.7M | $547.4M | $631.1M | $738.7M | $737.7M | |
Operating Income | $6.8M | $182.2M | $206.2M | $141.9M | $130.2M | |
Net Interest Expenses | $66.2M | $53.4M | $64.7M | $99.6M | $73.4M | |
EBT. Incl. Unusual Items | -$59.4M | $77.9M | $124.3M | $47.1M | $49.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $4.1M | -$5.5M | $39.6M | -$6M | $20.4M | |
Net Income to Company | -$63.5M | $83.4M | $84.7M | $53.1M | $29M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$63.5M | $83.4M | $84.7M | $53.1M | $29M | |
Basic EPS (Cont. Ops) | -$0.40 | $0.52 | $0.53 | $0.35 | $0.18 | |
Diluted EPS (Cont. Ops) | -$0.40 | $0.52 | $0.53 | $0.34 | $0.17 | |
Weighted Average Basic Share | $160.5M | $160.5M | $160.5M | $151M | $160.9M | |
Weighted Average Diluted Share | $160.5M | $160.5M | $160.5M | $156.2M | $166.7M | |
EBITDA | $60.5M | $174.2M | $244.8M | $201.8M | $186.8M | |
EBIT | $1.1M | $126.8M | $189M | $140.6M | $117.2M | |
Revenue (Reported) | $834M | $1.2B | $1.4B | $1.5B | $1.5B | |
Operating Income (Reported) | $6.8M | $182.2M | $206.2M | $141.9M | $130.2M | |
Operating Income (Adjusted) | $1.1M | $126.8M | $189M | $140.6M | $117.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $252.8M | $327.5M | $345.7M | $354.2M | $370.1M | |
Revenue Growth (YoY) | -- | 29.52% | 5.56% | 2.46% | 4.51% | |
Cost of Revenues | $96.4M | $144M | $145.8M | $158.2M | $168.5M | |
Gross Profit | $156.5M | $183.5M | $199.9M | $196M | $201.6M | |
Gross Profit Margin | 61.89% | 56.04% | 57.84% | 55.34% | 54.48% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $93.3M | $128.8M | $159.9M | $161.4M | $171.9M | |
Other Inc / (Exp) | $2.5M | -$3.3M | -$2.5M | -$2.1M | $1.4M | |
Operating Expenses | $119.8M | $150.6M | $184.2M | $179.7M | $191.2M | |
Operating Income | $36.7M | $33M | $15.8M | $16.3M | $10.4M | |
Net Interest Expenses | $17.3M | $14.4M | $26.9M | $19.1M | $17.5M | |
EBT. Incl. Unusual Items | $21.9M | $15.2M | -$13.6M | -$5M | -$5.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.8M | $3.3M | -$3.4M | -$4.5M | -$941K | |
Net Income to Company | $19M | $11.9M | -$10.2M | -$467K | -$4.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $19M | $11.9M | -$10.2M | -$467K | -$4.7M | |
Basic EPS (Cont. Ops) | $0.12 | $0.07 | -$0.06 | -- | -$0.03 | |
Diluted EPS (Cont. Ops) | $0.12 | $0.07 | -$0.06 | -- | -$0.03 | |
Weighted Average Basic Share | $160.5M | $160.5M | $160.5M | $161.2M | $158.6M | |
Weighted Average Diluted Share | $160.5M | $160.5M | $160.5M | $161.2M | $158.6M | |
EBITDA | $49.6M | $41.3M | $26.3M | $31M | $29.7M | |
EBIT | $37.4M | $28.7M | $11.8M | $12.7M | $10.4M | |
Revenue (Reported) | $252.8M | $327.5M | $345.7M | $354.2M | $370.1M | |
Operating Income (Reported) | $36.7M | $33M | $15.8M | $16.3M | $10.4M | |
Operating Income (Adjusted) | $37.4M | $28.7M | $11.8M | $12.7M | $10.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $1.3B | $1.5B | $1.5B | $1.6B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $522.1M | $601.7M | $632.1M | $680.1M | |
Gross Profit | -- | $756.7M | $853.7M | $876.7M | $873.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $505.7M | $606.4M | $679.1M | $685.9M | |
Other Inc / (Exp) | $293.7M | -$56.9M | -$16.4M | $5.2M | -$3.8M | |
Operating Expenses | -- | $578.2M | $664.7M | $734.3M | $749.2M | |
Operating Income | -- | $178.5M | $189M | $142.4M | $124.3M | |
Net Interest Expenses | $56.4M | $50.4M | $77.2M | $91.8M | $71.8M | |
EBT. Incl. Unusual Items | -- | $71.2M | $95.4M | $55.8M | $48.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -$5.1M | $32.8M | -$7.1M | $24M | |
Net Income to Company | -- | $76.3M | $62.6M | $62.8M | $24.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | $76.3M | $62.6M | $62.8M | $24.8M | |
Basic EPS (Cont. Ops) | -- | $0.48 | $0.39 | $0.42 | $0.15 | |
Diluted EPS (Cont. Ops) | -- | $0.48 | $0.39 | $0.41 | $0.15 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | $165.8M | $229.7M | $206.6M | $185.5M | |
EBIT | -- | $118.1M | $172.2M | $141.6M | $114.9M | |
Revenue (Reported) | -- | $1.3B | $1.5B | $1.5B | $1.6B | |
Operating Income (Reported) | -- | $178.5M | $189M | $142.4M | $124.3M | |
Operating Income (Adjusted) | -- | $118.1M | $172.2M | $141.6M | $114.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $252.8M | $327.5M | $345.7M | $354.2M | $370.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $96.4M | $144M | $145.8M | $158.2M | $168.5M | |
Gross Profit | $156.5M | $183.5M | $199.9M | $196M | $201.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $93.3M | $128.8M | $159.9M | $161.4M | $171.9M | |
Other Inc / (Exp) | $2.5M | -$3.3M | -$2.5M | -$2.1M | $1.4M | |
Operating Expenses | $119.8M | $150.6M | $184.2M | $179.7M | $191.2M | |
Operating Income | $36.7M | $33M | $15.8M | $16.3M | $10.4M | |
Net Interest Expenses | $17.3M | $14.4M | $26.9M | $19.1M | $17.5M | |
EBT. Incl. Unusual Items | $21.9M | $15.2M | -$13.6M | -$5M | -$5.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.8M | $3.3M | -$3.4M | -$4.5M | -$941K | |
Net Income to Company | $19M | $11.9M | -$10.2M | -$467K | -$4.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $19M | $11.9M | -$10.2M | -$467K | -$4.7M | |
Basic EPS (Cont. Ops) | $0.12 | $0.07 | -$0.06 | -- | -$0.03 | |
Diluted EPS (Cont. Ops) | $0.12 | $0.07 | -$0.06 | -- | -$0.03 | |
Weighted Average Basic Share | $160.5M | $160.5M | $160.5M | $161.2M | $158.6M | |
Weighted Average Diluted Share | $160.5M | $160.5M | $160.5M | $161.2M | $158.6M | |
EBITDA | $49.6M | $41.3M | $26.3M | $31M | $29.7M | |
EBIT | $37.4M | $28.7M | $11.8M | $12.7M | $10.4M | |
Revenue (Reported) | $252.8M | $327.5M | $345.7M | $354.2M | $370.1M | |
Operating Income (Reported) | $36.7M | $33M | $15.8M | $16.3M | $10.4M | |
Operating Income (Adjusted) | $37.4M | $28.7M | $11.8M | $12.7M | $10.4M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $137.2M | $97.9M | $112.1M | $180M | $150M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $8.9M | $6.6M | $14.1M | $11.8M | $16.8M | |
Inventory | $21.6M | $24.4M | $21.8M | $32.8M | $34.3M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $10.3M | $28.8M | $35.6M | $25.7M | $24.6M | |
Total Current Assets | $178.6M | $157.7M | $192.3M | $257.9M | $230.2M | |
Property Plant And Equipment | $120M | $133.9M | $628.4M | $728.8M | $822.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $485.8M | $703.8M | $681.4M | $687.4M | $665.5M | |
Other Intangibles | $179.4M | $208.8M | $170.7M | $166.7M | $159.3M | |
Other Long-Term Assets | $1.8M | $3.5M | $4M | $3.1M | $3.8M | |
Total Assets | $965.6M | $1.2B | $1.7B | $1.9B | $1.9B | |
Accounts Payable | $66.7M | $73M | $80.7M | $92.6M | $83M | |
Accrued Expenses | $53.7M | $76M | $62M | $65.1M | $52.3M | |
Current Portion Of Long-Term Debt | $5.5M | $8.4M | $50.3M | $4.5M | $6M | |
Current Portion Of Capital Lease Obligations | -- | -- | $79.8M | $79.3M | $89.8M | |
Other Current Liabilities | $3.5M | $3.8M | -- | -- | -- | |
Total Current Liabilities | $129.4M | $161.2M | $272.9M | $241.5M | $231.1M | |
Long-Term Debt | $598.3M | $790.7M | $783.3M | $784.6M | $735.1M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $791.7M | $1B | $1.5B | $1.5B | $1.5B | |
Common Stock | $223.9M | $224.7M | -- | -- | -- | |
Other Common Equity Adj | $12.1M | $14.5M | $39.5M | $30.5M | $14.2M | |
Common Equity | $173.9M | $185.4M | $227.3M | $376.1M | $421.7M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $173.9M | $185.4M | $227.3M | $376.1M | $421.7M | |
Total Liabilities and Equity | $965.6M | $1.2B | $1.7B | $1.9B | $1.9B | |
Cash and Short Terms | $137.2M | $97.9M | $112.1M | $180M | $150M | |
Total Debt | $603.8M | $799.1M | $833.6M | $789.1M | $741.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $91.8M | $93M | $102.2M | $73M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | $9.3M | $13.4M | $12.6M | $17.8M | |
Inventory | -- | $23.7M | $25.2M | $35.3M | $39.1M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | $16.7M | $38.4M | $31.9M | $31.3M | |
Total Current Assets | -- | $143.2M | $178M | $218.1M | $164.3M | |
Property Plant And Equipment | -- | $606.1M | $642.4M | $751.3M | $858.2M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | $708.7M | $682.1M | $681.5M | $667.1M | |
Other Intangibles | -- | $177.9M | $169.5M | $164M | $158.4M | |
Other Long-Term Assets | -- | $3M | $3.9M | $3.1M | $3.7M | |
Total Assets | -- | $1.7B | $1.7B | $1.8B | $1.9B | |
Accounts Payable | -- | $75.3M | $79.5M | $93.4M | $78.6M | |
Accrued Expenses | -- | $47.3M | $47.8M | $44M | $49M | |
Current Portion Of Long-Term Debt | -- | $33.3M | $38.3M | $6M | -- | |
Current Portion Of Capital Lease Obligations | -- | $78.5M | $72.1M | $77.8M | $93.7M | |
Other Current Liabilities | -- | $1.9M | -- | -- | -- | |
Total Current Liabilities | -- | $236.3M | $237.6M | $221.3M | $221.3M | |
Long-Term Debt | -- | $786.8M | $1.1B | $735.9M | $699.3M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $1.4B | $1.8B | $1.4B | $1.4B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | $23.5M | $35.5M | $27.8M | $12.2M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | $206.6M | -$48.4M | $395M | $413.8M | |
Total Liabilities and Equity | -- | $1.7B | $1.7B | $1.8B | $1.9B | |
Cash and Short Terms | -- | $91.8M | $93M | $102.2M | $73M | |
Total Debt | -- | $820M | $1.1B | $741.9M | $699.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$63.5M | $83.4M | $84.7M | $53.1M | $29M | |
Depreciation & Amoritzation | $59.4M | $47.4M | $55.8M | $61.1M | $69.5M | |
Stock-Based Compensation | $354K | $732K | $1.9M | $72.6M | $61.6M | |
Change in Accounts Receivable | $4.2M | $3.9M | -$8.1M | $740K | -$5.7M | |
Change in Inventories | $2.6M | $6.1M | $2.2M | -$10.9M | -$1.9M | |
Cash From Operations | $29.9M | $175.8M | $169.4M | $175.2M | $134.3M | |
Capital Expenditures | $19.2M | $40.5M | $110.2M | $92.4M | $105.9M | |
Cash Acquisitions | -- | -$220.3M | -- | -- | -$3.2M | |
Cash From Investing | -$19.2M | -$263.2M | -$110.5M | -$92.4M | -$80.5M | |
Dividends Paid (Ex Special Dividend) | -- | -$75M | -$69.4M | -$262.2M | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $42.1M | $817.1M | $102M | $571.2M | -- | |
Long-Term Debt Repaid | -$48.8M | -$645.7M | -$71M | -$633.5M | -$57.1M | |
Repurchase of Common Stock | -- | -- | -$292K | -$849K | -$560K | |
Other Financing Activities | -$1.5M | -$43.5M | -$1.5M | -$6.5M | $9M | |
Cash From Financing | $36.8M | $53M | -$40.2M | -$17M | -$76.6M | |
Beginning Cash (CF) | $86.3M | $137.9M | $97.9M | $112.1M | $180M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $47.5M | -$34.4M | $18.7M | $65.8M | -$22.9M | |
Ending Cash (CF) | $137.9M | $97.9M | $112.1M | $180M | $150M | |
Levered Free Cash Flow | $10.7M | $135.2M | $59.3M | $82.8M | $28.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $19M | $11.9M | -$10.2M | -$467K | -$4.7M | |
Depreciation & Amoritzation | $12.3M | $12.6M | $14.5M | $18.3M | $19.4M | |
Stock-Based Compensation | $178K | $162K | $917K | $19.1M | $11.5M | |
Change in Accounts Receivable | $1.6M | -$2.6M | -$1M | -$683K | -$988K | |
Change in Inventories | $614K | $713K | -$3.3M | -$2.6M | -$4.7M | |
Cash From Operations | $23.5M | $1.6M | -$14.8M | -$5.8M | $419K | |
Capital Expenditures | $5M | $25.8M | $20.8M | $22.5M | $20.6M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$5M | -$26.9M | -$20.9M | -$22.6M | -$19.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$262.2M | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $53M | $564.2M | -- | -- | |
Long-Term Debt Repaid | -$1.4M | -$32.8M | -$282.5M | -$51.3M | -$45.2M | |
Repurchase of Common Stock | -- | -- | -$345K | -- | -$170K | |
Other Financing Activities | -- | -$1.2M | -$2.6M | $766K | -$1.3M | |
Cash From Financing | -$1.4M | $19M | $16.6M | -$47.6M | -$58.5M | |
Beginning Cash (CF) | $137.9M | $97.9M | $112.1M | $180M | $150M | |
Foreign Exchange Rate Adjustment | $1.3M | $1.3M | -$124K | -$1.8M | $526K | |
Additions / Reductions | $17.1M | -$6.3M | -$19.1M | -$76M | -$77.5M | |
Ending Cash (CF) | $156.3M | $93M | $93M | $102.2M | $73M | |
Levered Free Cash Flow | $18.5M | -$24.2M | -$35.6M | -$28.3M | -$20.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | $76.3M | $62.6M | $62.8M | $24.8M | |
Depreciation & Amoritzation | -- | $47.8M | $57.6M | $65M | $70.6M | |
Stock-Based Compensation | $493K | $716K | $2.7M | $90.8M | $54M | |
Change in Accounts Receivable | -- | -$338K | -$6.5M | $1.1M | -$6.1M | |
Change in Inventories | -- | $6.2M | -$1.8M | -$10.2M | -$4M | |
Cash From Operations | -- | $153.8M | $153M | $184.2M | $140.5M | |
Capital Expenditures | $10.2M | $61.4M | $105.2M | $94.1M | $104M | |
Cash Acquisitions | -- | -- | -- | -- | -$3.2M | |
Cash From Investing | -- | -$285.1M | -$104.5M | -$94.1M | -$77.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$331.7M | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $870.1M | $613.2M | $7M | -- | |
Long-Term Debt Repaid | -- | -$677.1M | -$320.7M | -$402.3M | -$51M | |
Repurchase of Common Stock | -- | -- | -$637K | -$504K | -$730K | |
Other Financing Activities | -- | -$44.7M | -$2.9M | -$3.1M | $6.9M | |
Cash From Financing | -- | $73.4M | -$42.6M | -$81.3M | -$87.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -$57.8M | $5.9M | $8.8M | -$24.4M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | $92.5M | $47.9M | $90.1M | $36.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $19M | $11.9M | -$10.2M | -$467K | -$4.7M | |
Depreciation & Amoritzation | $12.3M | $12.6M | $14.5M | $18.3M | $19.4M | |
Stock-Based Compensation | $178K | $162K | $917K | $19.1M | $11.5M | |
Change in Accounts Receivable | $1.6M | -$2.6M | -$1M | -$683K | -$988K | |
Change in Inventories | $614K | $713K | -$3.3M | -$2.6M | -$4.7M | |
Cash From Operations | $23.5M | $1.6M | -$14.8M | -$5.8M | $419K | |
Capital Expenditures | $5M | $25.8M | $20.8M | $22.5M | $20.6M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$5M | -$26.9M | -$20.9M | -$22.6M | -$19.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$262.2M | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $53M | $564.2M | -- | -- | |
Long-Term Debt Repaid | -$1.4M | -$32.8M | -$282.5M | -$51.3M | -$45.2M | |
Repurchase of Common Stock | -- | -- | -$345K | -- | -$170K | |
Other Financing Activities | -- | -$1.2M | -$2.6M | $766K | -$1.3M | |
Cash From Financing | -$1.4M | $19M | $16.6M | -$47.6M | -$58.5M | |
Beginning Cash (CF) | $137.9M | $97.9M | $112.1M | $180M | $150M | |
Foreign Exchange Rate Adjustment | $1.3M | $1.3M | -$124K | -$1.8M | $526K | |
Additions / Reductions | $17.1M | -$6.3M | -$19.1M | -$76M | -$77.5M | |
Ending Cash (CF) | $156.3M | $93M | $93M | $102.2M | $73M | |
Levered Free Cash Flow | $18.5M | -$24.2M | -$35.6M | -$28.3M | -$20.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.